SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

ACZ885-IL1B: Receptors 

Prev Next
Previous

Bacteria Persister

medical illustration of One in a series for method of action of new medication targeting IL1B inhibition.
Next medical illustration of PowerPoint images and design for pharmaceutical method-of-action of Tivantinib, designed to block the activity of a molecule known as c-Met that plays multiple key roles in human cancer.

Tivantinib®: MET receptor and HGF ligand

One in a series for method of action of new medication targeting IL1B inhibition.

Keywords: Airbrush, Color, Line with Color, Advertising / Marketing, Education, Stock, Web, Cell biology / Histology, Disease Management, Embryology, Endocrinology / Metabolic, Molecular Biology, Pharmacology, Virology

© Mica Duran